40 novel genetic markers for glaucoma identified

Image
IANS Sydney
Last Updated : Jul 28 2018 | 2:05 PM IST

Australian researchers have identified 40 new genetic markers that increase a person's risk of developing glaucoma, a finding that may lead to improvements in diagnoses and treatment of the leading cause of irreversible blindness in the world.

The study showed that individuals with a large number of the genetic markers had an almost six-fold increased risk of developing glaucoma compared to someone who had fewer genetic variants, Xinhua news agency reported.

A person's risk of developing glaucoma -- which damages the optic nerve and leads to a gradual loss of the peripheral vision -- increased with age, but the high eye pressure commonly associated with glaucoma can be treated with drugs and even surgery.

"The discovery of these previously unknown genetic markers for glaucoma will be important for improving our ability to test for and predict a person's risk of the disease," Stuart MacGregor, Associate Professor at the QIMR Berghofer Medical Research Institute, said in a statement.

"Although a predictive test for glaucoma is not available yet, our discovery is very promising.

"If we can identify who is most at risk of developing glaucoma at the earliest opportunity, we can make sure those individuals receive the preventative treatment they need to stop them from going blind as they age," MacGregor said.

The results were published in the journal Nature Genetics.

For the study, the team covered more than 134,000 people linked to fluid pressure in the eye, a condition known as intraocular pressure -- commonly associated with an increased risk of developing glaucoma.

In 2013 an estimated 64.3 million people worldwide had the disease, increasing to 76 million in 2020 and 111.8 million in 2040, according to studies.

While currently there is no cure for the disease, early detection through screening can halt or significantly slow its progression.

The findings dramatically increased the current understanding of which genes caused glaucoma and high eye pressure, the researchers noted.

--IANS

rt/mag/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 28 2018 | 2:02 PM IST

Next Story